Llwytho...

Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC

Non-small cell lung cancer (NSCLC) represents the paradigm of personalized treatment of human cancer. Several oncogenic druggable alterations have been so far identified, with anaplastic lymphoma kinase (ALK) gene rearrangements being one of the newest and most appealing. Presence of ALK fusions is...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transl Lung Cancer Res
Prif Awduron: Landi, Lorenza, Cappuzzo, Federico
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2016
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5233871/
https://ncbi.nlm.nih.gov/pubmed/28149753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.12.05
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!